Compugen
CGEN
$2.52
Share price
3.28%
Change (1 day)
137.74%
Change (1 year)
Categories
Compugen (CGEN) - P/B ratio
P/B ratio as of May 2024 : 3.66
According to Compugen's latest financial reports the company has a price-to-book ratio of 3.66.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Compugen - P/B ratio (from 2001 to 2024)
P/B ratio by year
| Year | P/B ratio | Change |
|---|---|---|
| 2024-12-31 | N/A | -100% |
| 2023-12-31 | 2.67 | 233.71% |
| 2022-12-31 | 0.7994 | -76.23% |
| 2021-12-31 | 3.36 | -59.79% |
| 2020-12-31 | 8.36 | -21.64% |
| 2019-12-31 | 10.7 | 195.54% |
| 2018-12-31 | 3.61 | -17.5% |
| 2017-12-31 | 4.38 | 6.62% |
| 2016-12-31 | 4.11 | 16.51% |
| 2015-12-31 | 3.52 | -11.02% |
| 2014-12-31 | 3.96 | -64.74% |
| 2013-12-31 | 11.2 | 9.55% |
| 2012-12-31 | 10.3 | 16.86% |
| 2011-12-31 | 8.77 | 30.52% |
| 2010-12-31 | 6.72 | 15.54% |
| 2009-12-31 | 5.82 | 374.7% |
| 2008-12-31 | 1.23 | -53.25% |
| 2007-12-31 | 2.62 | -7.49% |
| 2006-12-31 | 2.83 | -13.4% |
| 2005-12-31 | 3.27 | 13.6% |
| 2004-12-31 | 2.88 | 27.07% |
| 2003-12-31 | 2.27 | 236.17% |
| 2002-12-31 | 0.6744 |
P/B ratio for similar companies or competitors
| Company | P/B ratio | differencediff. | Country |
|---|---|---|---|
 Seagen
SGEN | 16.9 | 362.23% | 🇺🇸 USA |
 Genetic Technologies GENE | 2.93 | -20.10% | 🇦🇺 Australia |
 Teva Pharmaceutical Industries TEVA | 2.53 | -31.01% | 🇮🇱 Israel |
 Eterna Therapeutics ERNA | -3.27 | -189.23% | 🇺🇸 USA |